By: Sebastian D. Schubl, MD, FACS & Zachary M. Bauman, DO, MHA
This course has expired. You can still review the content but course credit is no longer available.
This webinar, featuring Sebastian D. Schubl, MD, FACS, and Zachary M. Bauman, DO, MHA, includes a review of the growing literature on the use of surgical stabilization of rib fractures (SSRF). Emerging as the new standard of care, Drs. Schubl and Bauman discuss how SSRF compares with conventional treatment modalities related to length of hospital stay, thoracic deformity, pulmonary function, return to prefracture activities, as well as health care-related economics.
Supported by an unrestricted educational grant from Zimmer Biomet.
Upon completion of this activity, participants should be able to:
Provided by Evolve Medical Education
Accreditation Statement
Evolve Medical Education LLC is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Credit Designation Statement
Evolve Medical Education LLC designates this enduring material for a maximum of 1 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
In order to obtain credit, proceed through the program, complete the post-test, evaluation and submit for credit.
Course Viewing Requirements
Supported Browsers:
-Internet Explorer 11 for Windows
-Edge (recent versions; Chromium-based) for Windows
-Google Chrome (recent versions) for Windows, Mac OS, iOS, Android, or Linux
-Mozilla Firefox (recent versions) for Windows, Mac OS, iOS, Android, or Linux
-Safari (recent versions) for Mac OSX, or iOS
Hardware Requirements:
-4GB+ RAM
-Recommended internet speed 5Mbps+
Sebastian D. Schubl, MD, FACS
Chief, Emergency General Surgery
UCI Health
Associate Professor
Division of Trauma & Critical Care Surgery
Department of Surgery
University of California, Irvine
School of Medicine
Zachary M. Bauman, DO, MHA
Assistant Professor
Department of Surgery
University of Nebraska Medical Center
DISCLOSURE POLICY
It is the policy of Evolve that faculty and other individuals who are in the position to control the content of this activity disclose any real or apparent conflict of interests relating to the topics of this educational activity. Evolve has full policies in place that will identify and mitigate all conflicts of interest prior to this educational activity.
The following faculty/staff members have the following financial relationships with commercial interests:
Sebastian D. Schubl, MD, FACS has had a financial agreement or affiliation during the past year with the following commercial interests in the form of Consultant: Zimmer Biomet.
Zachary M. Bauman, DO, MHA has had a financial agreement or affiliation during the past year with the following commercial interests in the form of Consultant: Zimmer Biomet.
The Evolve staff and planners have no financial relationships with commercial interests.
Justin C. Muste, MD, peer reviewer, has no financial relationships with commercial interests.
OFF-LABEL STATEMENT
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The opinions expressed in the educational activity are those of the faculty. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
DISCLAIMER
The views and opinions expressed in this educational activity are those of the faculty and do not necessarily represent the views of Evolve or Zimmer Biomet.